-
Sagent's injectable antibiotics enter market
SCHAUMBURG, Ill. Generic drug maker Sagent Pharmaceuticals has launched two injectable antibiotics, the company said Tuesday.
Sagent announced the launch of ampicillin and ampicillin with sulbactam. Ampicillin had sales of around $42 million during the 12-month period ended in June, while ampicillin with sulbactam had sales of around $40 million during the same period, according to IMS Health.
-
FDA approves Par and Tris Pharma's generic Tussionex
WOODCLIFF LAKE, N.J. The Food and Drug Administration has approved a generic treatment for cough and upper respiratory symptoms resulting from colds and allergies made by Par Pharmaceutical and Tris Pharma, Par said Tuesday.
The FDA approved hydrocodone polistirex and chlorpheniramine polistirex extended-release oral suspension. The drug is a generic version of UCB’s Tussionex, which has annual sales of around $226 million, according to IMS Health.